Drugs / therapeutic cytotoxic T lymphocytes
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00871481 | Feb 2009 → Sep 2013 | melanoma | Fred Hutchinson Cancer Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | therapeutic cytotoxic T lymphocytes | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00871481 ↗ |
| Modality | Cell therapy | “adoptively transferred cytotoxic lymphocytes (CTL)” NCT00871481 ↗ |
| Route | Intravenous | “therapeutic cytotoxic T lymphocytes IV over 30-60 minutes” NCT00871481 ↗ |